ResearcherRutgers New Jersey Medical SchoolActive in the last 2 years

Neal S. Panse

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2198-8452; OpenAlex author ID A5006966542. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

Cost-effectiveness of staging laparoscopy with peritoneal cytology in pancreatic adenocarcinoma. First author DOI 10.1016/j.cpsurg.2024.101442 ↗
Staging CT and Diagnostic Laparoscopy With Cytology Prior to the Treatment of Pancreatic Adenocarcinoma: A Case Series. Co-author DOI 10.7759/cureus.31883 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ravi J. Chokshi · 2 shared papers, 2022–2024 · strength 0.44
- Paper Cost-effectiveness of staging laparoscopy with peritoneal cytology in pancreatic adenocarcinoma. DOI 10.1016/j.cpsurg.2024.101442 ↗
- Paper Staging CT and Diagnostic Laparoscopy With Cytology Prior to the Treatment of Pancreatic Adenocarcinoma: A Case Series. DOI 10.7759/cureus.31883 ↗
Simran Arjani · 2 shared papers, 2022–2024 · strength 0.44
- Paper Cost-effectiveness of staging laparoscopy with peritoneal cytology in pancreatic adenocarcinoma. DOI 10.1016/j.cpsurg.2024.101442 ↗
- Paper Staging CT and Diagnostic Laparoscopy With Cytology Prior to the Treatment of Pancreatic Adenocarcinoma: A Case Series. DOI 10.7759/cureus.31883 ↗
Maya Jodidio · 1 shared paper, 2024 · strength 0.26
- Paper Cost-effectiveness of staging laparoscopy with peritoneal cytology in pancreatic adenocarcinoma. DOI 10.1016/j.cpsurg.2024.101442 ↗
Patrick L. Quinn · 1 shared paper, 2022 · strength 0.19
- Paper Staging CT and Diagnostic Laparoscopy With Cytology Prior to the Treatment of Pancreatic Adenocarcinoma: A Case Series. DOI 10.7759/cureus.31883 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.